MONKEYPOX (MPOX)
Clinical trials for MONKEYPOX (MPOX) explained in plain language.
Never miss a new study
Get alerted when new MONKEYPOX (MPOX) trials appear
Sign up with your email to follow new studies for MONKEYPOX (MPOX), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New mpox vaccine trial launches in congo – could protect thousands
⭐️ VACCINE ⭐️ Not yet recruitingThis study tests a new vaccine called MVA-SIBP to see if it is safe and helps the body fight mpox (monkeypox). About 180 people in the Democratic Republic of the Congo will take part, including adults, teenagers, and children. Half will get the vaccine and half a placebo, and res…
Matched conditions: MONKEYPOX (MPOX)
Phase: PHASE2 • Sponsor: Shanghai Institute Of Biological Products • Aim: ⭐️ VACCINE ⭐️
Last updated May 15, 2026 11:54 UTC
-
Mpox booster shot under the microscope: 2-Year immune watch begins
Knowledge-focused Not yet recruitingThis study will follow 95 adults who receive a booster dose of the MVA-BN vaccine against mpox. Researchers will collect blood and other samples over two years to track how the immune system responds. The goal is to understand how long protection lasts after a booster, not to tes…
Matched conditions: MONKEYPOX (MPOX)
Sponsor: Institute of Tropical Medicine, Belgium • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC